Nirmala Bhoo Pathy: Our new study outlines key metrics for tracking progress and ensuring quality cancer care in the low- and middle-income countries
Nirmala Bhoo Pathy shared on LinkedIn:
“Our new study outlines key metrics for tracking progress and ensuring quality cancer care in the low- and middle-income countries. We used a Delphi method to pinpoint crucial indicators for areas like diagnosis, treatment, and patient experience.
It is envisioned that use of these quality indicators will facilitate health systems and all cancer stakeholders to
– track progress in delivering quality cancer care
– implement targeted interventions for improvement
– advocate for increased resources and support.”
Proceed to the article.
Source: Nirmala Bhoo Pathy/LinkedIn
Nirmala Bhoo-Pathy is a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician at Universiti Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014.
Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy. Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN).
She currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems. As the founder and scientific lead of a solution-oriented research group ‘Well with Cancer in Malaysia (WeCan@MY) https://spm.um.edu.my/wecan@my/ in the Department of Social and Preventive Medicine, Nirmala Bhoo-Pathy currently oversees a wide range of studies on cancer care, cancer control and cancer policy, locally and globally.